AtheroGenics (AGIX) April option implied volatility Elevated at 155

September 27, 2006 7:38 AM EDT Send to a Friend
AtheroGenics (Nasdaq: AGIX) : AGIX focuses on the discovery, development and commercialization of novel drugs for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login